BCM
CME icon

Buckhead Capital Management’s CME Group CME Stock Holding History

Buckhead Capital Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
3,504
-23
-0.7% -$6.83K 0.39% 65
2025
Q4 		$963K Buy
3,527
+97
+3% +$26.4K 0.35% 61
2025
Q3 		$927K Sell
3,430
-9
-0.3% -$2.45K 0.34% 60
2025
Q2 		$948K Sell
3,439
-5,715
-62% -$1.55M 0.37% 61
2025
Q1 		$2.43M Buy
9,154
+169
+2% +$41.7K 0.78% 51
2024
Q4 		$2.09M Sell
8,985
-10
-0.1% -$2.3K 0.67% 53
2024
Q3 		$1.98M Sell
8,995
-92
-1% -$19K 0.63% 53
2024
Q2 		$1.79M Sell
9,087
-10,354
-53% -$2.14M 0.61% 56
2024
Q1 		$4.19M Buy
19,441
+149
+0.8% +$31.3K 1.42% 33
2023
Q4 		$4.06M Sell
19,292
-927
-5% -$198K 1.5% 24
2023
Q3 		$4.05M Sell
20,219
-885
-4% -$176K 1.68% 20
2023
Q2 		$3.91M Sell
21,104
-3,558
-14% -$658K 0.93% 38
2023
Q1 		$4.72M Buy
24,662
+258
+1% +$46.7K 1.11% 32
2022
Q4 		$4.1M Sell
24,404
-793
-3% -$138K 0.99% 39
2022
Q3 		$4.46M Buy
25,197
+4,758
+23% +$940K 1.16% 31
2022
Q2 		$4.18M Sell
20,439
-634
-3% -$134K 1.04% 34
2022
Q1 		$5.01M Sell
21,073
-106
-0.5% -$24.9K 1.08% 30
2021
Q4 		$4.84M Sell
21,179
-2,368
-10% -$521K 1.02% 34
2021
Q3 		$4.55M Buy
23,547
+2,897
+14% +$587K 1.02% 37
2021
Q2 		$4.39M Sell
20,650
-79
-0.4% -$16.7K 0.97% 40
2021
Q1 		$4.23M Sell
20,729
-191
-0.9% -$37.6K 0.99% 39
2020
Q4 		$3.81M Buy
20,920
+764
+4% +$130K 0.95% 40
2020
Q3 		$3.37M Buy
20,156
+198
+1% +$33.4K 0.96% 37
2020
Q2 		$3.24M Buy
19,958
+1,260
+7% +$226K 0.99% 39
2020
Q1 		$3.23M Buy
18,698
+2,555
+16% +$509K 1.21% 34
2019
Q4 		$3.24M Sell
16,143
-1,402
-8% -$288K 0.92% 43
2019
Q3 		$3.71M Buy
17,545
+853
+5% +$178K 1.06% 39
2019
Q2 		$3.24M Buy
16,692
+383
+2% +$70.6K 0.97% 41
2019
Q1 		$2.68M Sell
16,309
-7,636
-32% -$1.35M 0.84% 46
2018
Q4 		$4.5M Buy
23,945
+1,122
+5% +$207K 1.58% 26
2018
Q3 		$3.88M Sell
22,823
-310
-1% -$52.2K 1.19% 32
2018
Q2 		$3.79M Buy
23,133
+230
+1% +$37.6K 1.25% 33
2018
Q1 		$3.7M Sell
22,903
-3,853
-14% -$613K 0.82% 45
2017
Q4 		$3.91M Sell
26,756
-467
-2% -$66.5K 0.83% 44
2017
Q3 		$3.69M Sell
27,223
-23,116
-46% -$2.92M 0.79% 47
2017
Q2 		$6.3M Sell
50,339
-431
-0.8% -$51.5K 1.15% 31
2017
Q1 		$6.03M Buy
50,770
+172
+0.3% +$20.7K 1.11% 34
2016
Q4 		$5.84M Sell
50,598
-961
-2% -$107K 1.11% 33
2016
Q3 		$5.39M Sell
51,559
-980
-2% -$102K 1.03% 36
2016
Q2 		$5.12M Buy
52,539
+13,415
+34% +$1.27M 0.93% 40
2016
Q1 		$3.76M Buy
39,124
+257
+0.7% +$23.4K 0.7% 57
2015
Q4 		$3.52M Sell
38,867
-397
-1% -$37.4K 0.65% 54
2015
Q3 		$3.64M Sell
39,264
-740
-2% -$70.3K 0.71% 55
2015
Q2 		$3.72M Sell
40,004
-3,935
-9% -$367K 0.68% 54
2015
Q1 		$4.16M Sell
43,939
-3,970
-8% -$368K 0.74% 55
2014
Q4 		$4.25M Sell
47,909
-6,328
-12% -$536K 0.75% 46
2014
Q3 		$4.34M Sell
54,237
-17,065
-24% -$1.29M 0.75% 44
2014
Q2 		$5.06M Sell
71,302
-5,680
-7% -$400K 0.72% 50
2014
Q1 		$5.7M Sell
76,982
-2,900
-4% -$219K 0.72% 49
2013
Q4 		$6.27M Sell
79,882
-4,423
-5% -$346K 0.82% 44
2013
Q3 		$6.23M Buy
84,305
+4,850
+6% +$357K 0.86% 43
2013
Q2 		$6.04M Buy
+79,455
New +$5.21M 0.76% 47

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Buckhead Capital Management's CME Position: Q1 2026 in Review

Buckhead Capital Management reduced its CME Group (CME) stake by 0.65% in Q1 2026, selling an estimated $6.83K and leaving 3,504 shares worth $1.03M. The position accounts for 0.39% of the portfolio, ranked #65.

Buckhead Capital Management first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.3M in Q2 2017. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Buckhead Capital Management held 3,504 shares of CME Group worth $1.03M as of Q1 2026.
  • Buckhead Capital Management sold 23 CME Group shares in Q1 2026, an estimated $6.83K.
  • CME Group made up 0.39% of Buckhead Capital Management's portfolio in Q1 2026, its #65 holding.
  • Buckhead Capital Management first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Buckhead Capital Management's CME Group position peaked at $6.3M in Q2 2017.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Buckhead Capital Management's 13F filing for Q1 2026, filed 8 May 2026.